Hemostemix $HEM Market Insights
Hemostemix Inc. (
HEM) is an innovative-driven publicly-traded biotech company. Its principal business is developing, manufacturing, and commercializing innovative blood-derived stem cell therapies. The company is currently offering a trading volume of 130K+, followed by the 30-day estimated average volume of 240.6K.HEM
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.